The Benefits of Patient Self-Testing.
The warfarin black box warning calls for more frequent patient testing.
Patients who self-test on a weekly basis demonstrate a higher percentage of time in target therapeutic range (TTR) (greater than 70 percent) as compared to patients testing under usual care models.
Patients who self-test their INR are at a lower risk of adverse events.
A high percentage of patients can learn how to perform home INR testing and maintain the ability to self-test over time.
New labeling stresses bleeding risk from Coumadin. U.S. Food and Drug Administration. FDA Patient Safety News Web site. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/009218s107lbl.pdf Revised October 2011.
Heneghan C, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006; 367:404-11.
Ansell J, et al. STABLE Results: Warfarin Home Monitoring Achieves Excellent INR Control. American Journal of Managed Care. 2014;20(3):202-209. Available at: http://www.ajmc.com/journals/issue/2014/2014-vol20-n3/stable-results-warfarin-home-monitoring-achieves-excellent-inr-control
Bloomfield, et al. "Meta-analysis: Effect of Patient Self-testing and Self-management of Long-Term Anticoagulation on Major Clinical Outcomes." Ann Intern Med. 2011;154:472-82
Matchar, et al. "Effect of Home Testing of International Normalized Ratio on Clinical Events." New England Journal of Medicine. 2010;363:1608-20
The Benefits of Partnering with ODI Diagnostics.
Focus on your patients instead of in-office testing and data entry. Our experienced team and exceptional systems help you spend more time providing care instead of completing paperwork.
Increased Testing Compliance
Once your patient has received self-testing training, we ensure that he or she is adhering to your prescribed test frequency and other instructions. We will provide you with a report of all patients who have not tested after multiple reminders so you can adjust their treatment.